Biological, Chemical, and Physical Compatibility of Chitosan and Biopharmaceuticals

Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics

Volumn , Issue , 2012, Pages 93-106

  Ishihara, Masayuki ^a   Fujita, Masanori ^a   Kishimoto, Satoko ^a,b   Hattori, Hidemi ^a   Kanatani, Yasuhiro ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Biocompatibility testing; Biological, chemical, and physical compatibility of chitosan; Chitin, a natural polymer of N acetylglucosamine; Chitosan based gene delivery systems; Chitosan based peptide, protein delivery systems; Chitosan based products, and accurate study of biocompatibility; Foreign body reaction; Photo cross linkable chitosan hydrogel, and chitosan safety; Physical and chemical compatibility with biopharmaceuticals

Indexed keywords

EID: 84885545294     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119962977.ch6     Document Type: Chapter

References (89)

1. Nagpal, K., Singh, S.K. and Mishra, D.N. (2010) Chitosan nanoparticles: a promising system in novel drug delivery. Chem. Pharm. Bull., 58, 1423-1430.
2. Xu, Y.M. and Du, Y.M. (2003) Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm., 250, 215-226.
3. Kizilel, S. and Garfinkel, M. and Opara, E. (2005) The bioartificial pancreas: progress and challenges. Diabetes Technol. Ther., 7, 968-985.
4. Fine, D.M. and Tobias, A.H. (2007) Cardiovascular device infections in dogs: report of 8 cases and review of the literature. J. Vet. Intern. Med., 21, 1265-1271.
5. Hattori, H., Amano,Y., Nogami,Y. et al. (2010) Hemostasis for severe hemorrhage with photocrosslinkable chitosan hydrogel and calcium alginate. Ann. Biomed. Eng., 38, 3724-3732.
6. Horio, T., Ishihara, M., Fujita, M. et al. (2010) Hemostatic effects of photocrosslinkable chitosan hydrogel-mixed photocrosslinked chitosan sponges (PCM-S) on hepatic bleeding in rats. Artif. Organs, 34, 342-347.
7. Wilson, G.S., Zhang, Y., Reach, G. et al. (1992) Progress toward the development of an implantable sensor for glucose. Clin. Chem., 38, 1613-1617.
8. Koschwanez, H.E. and Reichert, W.M. (2007) In vitro, in vivo and post explantation testing of glucose-detecting biosensors: current methods and recommendations. Biomaterials, 28, 3687-3703.
9. Mi, F.-L., Tan, Y.-C., Liang, H.-F. and Sung, H.-W. (2002) In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials, 23, 181-191.
10. Shi, C., Zhu, Y., Ran, X. et al. (2006) Therapeutic potential of chitosan and its derivatives in regenerative medicine. J. Surg. Res., 133, 185-192.
11. Onuki, Y., Bhardwaj, U., Papadimitrakopoulos, F. and Burgess, D.J. (2008) A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J. Diabetes Sci. Tech., 2, 1003-1015.
12. Khor, E. and Lim, L.Y. (2003) Implantable applications of chitin and chitosan. Biomaterials, 24, 2339-2349.
13. VandeVord, P.J., Matthew, H.W.T., DeSilva, S.P. et al. (2001) Evaluation of the biocompatibility of a chitosan scaffold in mice. J. Biomed. Mater. Res., 59, 585-590.
14. Lee, D.W., Lim, H., Chong, H.N. and Shim,W.B. (2009) Advances in chitosan material and its hybrid derivatives: a review. Open Biomat. J., 1, 10-20.
15. Yen, M.-T., Yang, J.-H. and Mau, J.-L. (2009) Physicochemical characterization of chitin and chitosan from crab shells. Carbohydr. Polym., 75, 15-21.
16. Dutta, P.K., Dutta, J. and Tripathi, V.S. (2004) Chitin and chitosan: chemistry, properties and applications. J. Sci. Ind. Res., 63, 20-31.
17. de Souza, H.K.S., Bai, G., Gonçalves, M.P. and Bastos, M. (2009) Whey protein isolate-chitosan interactions: a calorimetric and spectroscopic study. Thermochim. Acta, 495, 108-114.
18. Shu, S., Zhang, S.X., Teng, D. et al. (2009) Polyelectrolyte nanoparticles based on water-soluble chitosan-poly (L-aspartic acid)-polyethylene glycol for controlled protein release. Carbohydr. Res., 344, 1197-1204.
19. Sarmento, B., Ferreira, D.C., Jorgensen, L. and van deWeert, M. (2007) Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles. Eur. J. Pharm. Biopharm., 65, 10-17.
20. Weber, C., Drogoz,A.,David, L. et al. (2010)Polysaccharide-basedvaccine delivery systems:macromolecularassembly, interactions with antigen presenting cells, and in vitro immunomonitoring. Biomed. Mater. Res., 93, 1322-1344.
21. Mao, H.-Q., Roy, K., Trong-Le, V.L. et al. (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release, 70, 399-421.
22. Anderson, J.M. (2001) Biological responses to material. Annu. Rev. Mater. Res., 31, 81-110.
23. Anderson, J.M. (1988) Inflammatory response to implants. ASAIO Trans., 34, 101-107.
24. Pober, J.S. and Cotran, R.S. (1990) The role of endothelial cells in inflammation. Transplantation, 50, 537-544.
25. Cotran, R.S. and Pober, J.S. (1990) Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J. Am. Soc. Nephrol., 1, 225-235.
26. Johnston, P.B. Jr (1988) Current concepts: immunology. Monocytes and macrophages. N. Engl. J. Med., 318, 747-752.
27. Thompson, J.A., Anderson, K.D., DiPietro, J.M. et al. (1988) Site-directed neovessel formation in vivo. Science, 241, 2349-1352.
28. Ziats, N.P., Miller, K.M. and Anderson, J.M. (1998) In vitro and in vivo interactions of cells with biomaterials. Biomaterials, 9, 5-13.
29. Arribas, S.M., Hinek, A. and Gonzalez, M.C. (2006) Elastic fibers and vascular structure in hypertension. Pharmacol. Ther., 111, 771-791.
30. Labat-Robert, J., Bihari-Varga, M. and Robert, L. (1990) Extracellular matrix. FEBS Lett., 268, 386-393.
31. Anderson, J.M., Rodriguez, A. and Chang, D.T. (2008) Foreign body reaction to biomaterials. Semin. Immunol., 20, 86-100.
32. Williams, D.F. (1987) Tissue-biomaterial interactions. J. Mater. Sci., 22, 3421-3445.
33. Ratner, B.D. and Bryant, S.J. (2004) Biomaterials: where we have been and where we are going. Annu. Rev. Biomed. Eng., 6, 41-75.
34. Ono, K., Ishihara, M., Ozeki, Y. et al. (2001) Experimental evaluation of photocrosslinkable chitosan as a biological adhesive with surgical application. Surgery, 130, 844-850.
35. Keong, L.C. and Halim, A.S. (2009) In vitro in biocompatibility assessment for biomedical-grade chitosan derivatives in wound management. Int. J. Mol. Sci., 10, 1300-1313.
36. Korting, H.C., Herzinger, T., Hartinger, A. et al. (1994) Discrimination of irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HacaT cells and 3T3 mouse fibroblasts: correlation with in vivo data from a soap chamber assay. J. Dermatol. Sci., 7, 119-129.
37. Lim, C.K., Yaacob, N.S., Ismail, Z. and Halim, A.S. (2010) In vitro biocompatibility of chitosan porous regenerating templates (PSRTs) using primary human skin keratinocytes. Toxicol. In Vitro, 24, 721-727.
38. Ostling, O. and Johanson, K.J. (1984) Microelectrotrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. Biophys. Res. Comm., 123, 291-298.
39. Singh, N.P., McCoy, M.T., Tice, R.R. and Schneider, C.P. (1988) A simple technique for quantitation of low levels of DNA damage individual cells. Exp. Cell Res., 175, 184-191.
40. Mitchelmore, C.L. and Chipman, J.K. (1998) DNA strand breakage in aquatic organisms and the potential value of the comet assay in environmental monitoring. Mutation Res., 399, 135-147.
41. Lazutka, J.R. (1996) Genetic toxicity of cytokine. Mutation Res., 361, 95-105.
42. Steinhoff, M., Brzoska, T. and Luger, T.A. (2003) Keratinocytes in epidermal immune responses. Curr. Opinion Allergy Clin. Immunol., 1, 469-476.
43. Harwell, J.D., Lammintausta, K. and Maibach, H.L. (1995) Irritant contact dermatitis, in Practical Contact Dermatitis (ed. J.D. Guin), McGraw-Hill, New York, NY.
44. Nixon, G.A., Tyson, C.A. and Wertz, W.C. (1975) Interspecies comparisons of skin irritancy. Toxicol. Appl. Pharmacol., 31, 481-490.
45. York, M., Griffiths, H.A., Whittle, E. and Basketter, D.A. (1996) Evaluation of a human patch test for the identification and classification of skin irritation potential. Contact Dermatitis, 34, 204-212.
46. Coquette, A., Poumay, Y. and Pittelkow, M.R. (2000) The keratinocyte in cutaneous irritation and sensitization, in Biochemical Modulation of Skin Reactions (eds A.F. Kydonieus and J.J. Wille), CRC Press, Boca Raton, FL.
47. Tizard, I.R. (2000) Immunity at body surface, in Veterinary Immunology. An Introduction, 6th edn(ed. I.R. Tizard), Saunders, Philadelphia, PA.
48. Grone, A. (2002) Keratinocytes and cytokines. Vet. Immunol. Immunopathol., 88, 1-12.
49. Ono, K., Saito,Y.,Yura, H. et al. (2000) Photocrosslinkable chitosan as a biological adhesive. J. Biomed. Mater. Res., 49, 289-295.
50. Otani, Y., Tabata, Y. and Ikada, Y. (1996) A new biological glue from gelatin and poly (L-glutamic acid). J. Biomed. Mater. Res., 31, 157-166.
51. Tseng, Y.C., Hyon, S.H. and Ikada, Y. (1990) Modification of synthesis and investigation of properties for 2- cyanoacrylates. Biomaterials, 11, 73-79.
52. Vanholder, R., Misotten, A., Roels, H. and Matton, G. (1993) Cyanoacrylate tissue adhesive for closing skin wounds: a double blind randomized comparison with suture. Biomaterials, 14, 737-743.
53. John, A., Rousou, M.D., Richard, M. et al. (1984) An effective hemostatic agent for nonsuturable intraoperative bleeding. Ann. Thorac. Surg., 38, 409-410.
54. Moy, O.J., Peimer, C.A., Koniuchi, M.P. et al. (1988) Fibrin seal adhesive versus nonadsorbable microsuture in peripheral nerve repair. J. Hand Surg., 13, 273-278.
55. Escott, G.M. and Adams, D.J. (1995) Chitinase activity in human serum and leukocytes. Infect. Immun., 63, 4770-4773.
56. Van deVord, P.J., Matthew, H.W., DeSilva, S.P. et al. (2002) Evaluation of the biocompatibility of a chitosan scaffold in mice. J. Biomed. Mater. Res., 59, 585-590.
57. Frank, S., Hubner, G., Breier, G. et al. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J. Biol. Chem., 270, 12607-12613.
58. Chavakis, T., Cines, D.B., Liang, O.D. et al. (2004) Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB. J., 18, 1306-1308.
59. Ishihara, M., Obara, K., Ishizuka, T. et al. (2003) Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res., 64, 551-559.
60. Kiyozumi, T., Kanatani, Y., Ishihara, M. et al. (2006) Medium (DMEM/F12)-containing chitosan hydrogel as adhesive and dressing in autologous skin grafts and accelerator in the healing process. J. Biomed. Mater. Res. B, 798, 129-136.
61. Ueno, H., Yamada, H., Tanaka, I. et al. (1999) Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials, 20, 1407-1414.
62. Ishihara, M., Nakanishi, K., Ono, K. et al. (2002) Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials, 23, 833-840.
63. Obara, K., Ishihara, M., Ishizuka, T. et al. (2003) Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials, 24, 3437-3444.
64. Danon, D., Kowatch, M.A. and Roth, G.S. (1989) Promotion of wound repair in old mice by local injection of macrophages. Proc. Natl. Acad. Sci. USA, 86, 2018-2020.
65. Shilpa, A., Agawal, S.S. and Ray, A.R. (2003) Controlled delivery of drugs from alginate matrix. JMS. Polym. Rev., C43, 187-196.
66. Yao, K.D., Liu, J., Cheng, G.X. et al. (1996) Swelling behavior of pectin/chitosan complex films. J. Appl. Polym. Sci., 60, 279-788.
67. Surrini, S., Akiyama, H., Morishita, M. et al. (2003) Release phenomena of insulin from an implantable device composed of polyion complex of chitosan and sodium hyaluronan. J. Control. Release, 90, 291-301.
68. Yao, Z.-A. andWu, H.-G. (2010) Characterization of chitosan-chondroitin sulfate blended membranes and effects on the growth of corneal cells. Adv. Mater. Lett., 1, 67-74.
69. Cheng, M., Deng, J., Yang, F. et al. (2003). Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions. Biomaterials, 24, 2871-2880.
70. Aiba, S. (1986) Studies on chitosan: 1. Determination of the degree of N-acetylation of chitosan by ultraviolet spectrophotometry and gel-permeation chromatography. Int. J. Biol. Macromol., 8, 173-176.
71. Liu, W., Sun, S., Cao, Z. et al. (2005) An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials, 26, 2705-2711.
72. Nielsen, L., Frokjaer, S., Carpenter, J. and Brange, J. (2001) Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy. J. Pharm. Sci., 90, 29-37.
73. Pocker, Y. and Biswas, S.B. (1980) Conformational dynamics of insulin in solution. Circular Dichroic Studies, Biochemistry, 19, 4043-4049.
74. Shirosaki, Y., Tsuru, K., Hayakawa, S. et al. (2005) In vitro cytocompatibility of MG63 cells on chitosanorganosiloxane hybrid membranes. Biomaterials, 26, 485-493.
75. Jung, B.-O., Na, J. and Kim, C.H. (2007) Synthesis of chitosan derivatives with anionic groups and its biocompatibility in vitro. J. Ind. Eng. Chem., 13, 772-776.
76. Ma, P.L., Lavertu, M., Winnik, F.M. and Buschmann, M.D. (2009) New insights into chitosan-DNA interactions using isothermal titration microcalorimetry. Biomacromolecules, 10, 1490-1499.
77. Li, X.W., Lee, D.K.L., Chan, A.S.C. and Alpar, H.O. (2003) Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochim. Biophys. Acta, 1630, 7-18.
78. Kissei, T., Mao, S. and Jintapattanakit, U. (2006)Aself-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J. Pharm. Sci., 95, 1035-1048.
79. Yu, S.Y., Hu, J.H., Pan, X.Y. et al. (2006) Stable and pH-sensitive nanogels prepared by self-assembly of chitosan and ovalbumin. Langmuir, 22, 2754-2759.
80. Chen, Y., Mohanraj, V.J. and Parkin, J.E. (2003) Chitosan-dextran sulfate nanoparticles for delivery of an antiangiogenesis peptide. Lett. Pept. Sci., 10, 621-629.
81. Seferian, P.G. and Martinez, M.I. (2000) Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine, 19, 661-668.
82. Drogoz, A., Munier, S., Verrier, B. et al. (2008) Towards biocompatible vaccine delivery systems: interactions of colloidal PECs based on polysaccharides with HIV-1 p24 antigen. Biomacromolecules, 9, 583-591.
83. Mumper, R.,Wang, J., Claspell, J. and Rolland, A.P. (1995) Novel polymeric condensing carriers for gene delivery. Proc. Int. Symp. Control. Release Bioact. Mater., 22, 178-179.
84. Kiang, T.,Wen, J., Lim, H.W. et al. (2004) The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials, 25, 5293-5301.
85. Lavertu, M., Methot, S., Tran-Khanh, N. and Buschmann, M.D. (2006) High efficiency gene transfer using chitosan/ DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials, 27, 4815-4825.
86. de la Fuente, M., Seijo, B. and Alonso, M.J. (2008) Design of novel polysaccharidic nanostructures for gene delivery. Nanotechnology, 19, 075105.
87. Miya, M., Iwamoto, R. and Yoshikawa, S. (1980) IR spectroscopic determination of CONH content in highly deacylated chitosan. Int. J. Biol. Macromol., 2, 323-324.
88. Xia, W., Liu, P., Zhang, J. and Chen, J. (2011) Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids, 25, 170-179.
89. DeValde, K.V. and Kiekens, P. (2004) Structure analysis and degree of substitution of chitin, chitosan and dibutyrylchitin by FTIR spectroscopy and solid state 13C-NMR. Carbohydr. Polym., 58, 409-416.